Amphastar Pharmaceuticals (AMPH) EBITDA Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) reported EBITDA Margin of 29.39% for Q2 2026, down 3.18 percentage points from 32.57% a year earlier but up 13.04 percentage points from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Amphastar Pharmaceuticals' EBITDA Margin came in at 23.48%, down 9.63 percentage points year-over-year; for FY2025, it came in at 27.38%, down 7.92 percentage points from FY2024.
- EBITDA Margin has a five-year change of +21.37 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 35.30% in FY2024 (-1.25 pp), 36.55% in FY2023 (+12.30 pp), 24.26% in FY2022 (+5.71 pp) and 18.54% in FY2021 (+12.54 pp).
- Five-year quarterly EBITDA Margin spans a low of 16.35% in Q1 2026 and a high of 49.00% in Q3 2023.
- Year over year, EBITDA Margin has now declined in each of the last eight quarters, with an average year-over-year change of -8.84 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q3 2023 (a gain of 26.63 percentage points); the low point was Q3 2025 (a drop of 17.62 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 16.35% (Q1 2026), 27.28% (Q4 2025) and 20.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Amphastar Pharmaceuticals | 1.13 Bn | -6.34 Mn | 93.47 Mn | 29.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.39% |
| Mar 31, 2026 | 16.35% |
| Dec 31, 2025 | 27.28% |
| Sep 30, 2025 | 20.56% |
| Jun 30, 2025 | 32.57% |
| Mar 31, 2025 | 29.85% |
| Dec 31, 2024 | 31.41% |
| Sep 30, 2024 | 38.19% |
| Jun 30, 2024 | 38.97% |
| Mar 31, 2024 | 37.15% |
| Dec 31, 2023 | 39.20% |
| Sep 30, 2023 | 49.00% |
| Jun 30, 2023 | 27.58% |
| Mar 31, 2023 | 26.48% |
| Dec 31, 2022 | 30.73% |
| Sep 30, 2022 | 22.37% |
| Jun 30, 2022 | 22.65% |
| Mar 31, 2022 | 20.53% |
| Dec 31, 2021 | 22.33% |
| Sep 30, 2021 | 24.64% |
API Access
Amphastar Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();